NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes: NeuroD1 and PAX4 polymorphisms and repaglinide efficacy

British Journal of Clinical Pharmacology(2012)

引用 34|浏览17
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要